Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exodeoxyribonucleases | 15 | 2015 | 18 | 2.590 |
Why?
|
| Phosphoproteins | 15 | 2015 | 54 | 2.520 |
Why?
|
| DNA | 10 | 2017 | 204 | 2.240 |
Why?
|
| Models, Molecular | 17 | 2017 | 178 | 1.460 |
Why?
|
| Ribonuclease H | 4 | 2015 | 7 | 1.320 |
Why?
|
| DNA Damage | 6 | 2017 | 88 | 1.160 |
Why?
|
| Bacterial Proteins | 5 | 2018 | 77 | 1.080 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2014 | 27 | 1.070 |
Why?
|
| Autoimmune Diseases of the Nervous System | 7 | 2018 | 7 | 1.050 |
Why?
|
| Nervous System Malformations | 7 | 2018 | 9 | 1.040 |
Why?
|
| Mutation | 13 | 2015 | 466 | 0.900 |
Why?
|
| Autoimmunity | 4 | 2018 | 26 | 0.830 |
Why?
|
| RNA | 2 | 2015 | 88 | 0.830 |
Why?
|
| Transcription Factors | 2 | 2012 | 172 | 0.790 |
Why?
|
| Cell Cycle | 2 | 2018 | 69 | 0.780 |
Why?
|
| Protein Multimerization | 7 | 2018 | 21 | 0.770 |
Why?
|
| Crystallography, X-Ray | 9 | 2015 | 77 | 0.760 |
Why?
|
| Crystallization | 2 | 2012 | 16 | 0.740 |
Why?
|
| Nitrophenols | 1 | 2018 | 3 | 0.680 |
Why?
|
| Mutation, Missense | 6 | 2014 | 48 | 0.660 |
Why?
|
| Immunity, Innate | 2 | 2018 | 64 | 0.640 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 162 | 0.630 |
Why?
|
| DNA, Single-Stranded | 4 | 2014 | 11 | 0.630 |
Why?
|
| Catalytic Domain | 8 | 2017 | 58 | 0.620 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 250 | 0.560 |
Why?
|
| Cysteine | 1 | 2017 | 131 | 0.550 |
Why?
|
| Ribonucleotides | 1 | 2015 | 2 | 0.520 |
Why?
|
| Autoimmune Diseases | 3 | 2011 | 50 | 0.510 |
Why?
|
| Neoplasms | 2 | 2018 | 612 | 0.510 |
Why?
|
| Kininogen, High-Molecular-Weight | 1 | 2014 | 6 | 0.500 |
Why?
|
| Escherichia coli Proteins | 3 | 2010 | 31 | 0.500 |
Why?
|
| Metals, Heavy | 1 | 2014 | 7 | 0.500 |
Why?
|
| Ferritins | 1 | 2014 | 46 | 0.490 |
Why?
|
| Protein Structure, Secondary | 6 | 2011 | 45 | 0.440 |
Why?
|
| DNA Replication | 2 | 2009 | 23 | 0.440 |
Why?
|
| Escherichia coli | 2 | 2010 | 82 | 0.430 |
Why?
|
| Genes, Bacterial | 1 | 2012 | 8 | 0.430 |
Why?
|
| Virulence Factors | 1 | 2012 | 8 | 0.430 |
Why?
|
| Response Elements | 1 | 2012 | 16 | 0.430 |
Why?
|
| Protein Binding | 7 | 2013 | 199 | 0.430 |
Why?
|
| Lupus Erythematosus, Cutaneous | 4 | 2015 | 13 | 0.390 |
Why?
|
| Mixed Function Oxygenases | 1 | 2010 | 12 | 0.370 |
Why?
|
| Humans | 28 | 2018 | 29220 | 0.360 |
Why?
|
| Protein Structure, Tertiary | 8 | 2012 | 95 | 0.360 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2008 | 1 | 0.340 |
Why?
|
| Nucleotides | 3 | 2018 | 16 | 0.340 |
Why?
|
| Protein Structure, Quaternary | 6 | 2014 | 15 | 0.330 |
Why?
|
| Substrate Specificity | 5 | 2011 | 84 | 0.310 |
Why?
|
| Macromolecular Substances | 1 | 2007 | 15 | 0.300 |
Why?
|
| DNA, Bacterial | 3 | 2014 | 17 | 0.300 |
Why?
|
| Nucleic Acid Conformation | 4 | 2015 | 46 | 0.270 |
Why?
|
| Binding Sites | 6 | 2008 | 125 | 0.270 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2018 | 9 | 0.260 |
Why?
|
| Cell Proliferation | 2 | 2018 | 573 | 0.260 |
Why?
|
| Catalysis | 6 | 2014 | 64 | 0.250 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 350 | 0.240 |
Why?
|
| Mice | 7 | 2015 | 2372 | 0.240 |
Why?
|
| Chilblains | 2 | 2015 | 3 | 0.240 |
Why?
|
| Amino Acid Sequence | 6 | 2012 | 280 | 0.230 |
Why?
|
| Protein Subunits | 2 | 2014 | 34 | 0.210 |
Why?
|
| Kinetics | 5 | 2011 | 205 | 0.200 |
Why?
|
| Amino Acid Substitution | 6 | 2014 | 40 | 0.190 |
Why?
|
| DNA Repair | 4 | 2017 | 50 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2013 | 145 | 0.190 |
Why?
|
| Protein Conformation | 4 | 2010 | 85 | 0.190 |
Why?
|
| Manganese | 2 | 2018 | 10 | 0.190 |
Why?
|
| Base Sequence | 5 | 2018 | 240 | 0.190 |
Why?
|
| Nucleic Acids | 2 | 2011 | 6 | 0.190 |
Why?
|
| Dimerization | 4 | 2008 | 24 | 0.180 |
Why?
|
| Apoptosis | 4 | 2018 | 337 | 0.180 |
Why?
|
| Syndrome | 3 | 2008 | 66 | 0.180 |
Why?
|
| Animals | 8 | 2015 | 7302 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 11 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2018 | 30 | 0.170 |
Why?
|
| Bordetella bronchiseptica | 1 | 2018 | 3 | 0.160 |
Why?
|
| Niacin | 1 | 2018 | 7 | 0.160 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 681 | 0.160 |
Why?
|
| Lysophospholipids | 1 | 2018 | 25 | 0.160 |
Why?
|
| DNA Adducts | 2 | 2008 | 13 | 0.160 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 20 | 0.150 |
Why?
|
| Circular Dichroism | 1 | 2017 | 30 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 114 | 0.150 |
Why?
|
| Exonucleases | 2 | 2008 | 2 | 0.150 |
Why?
|
| Cell Death | 3 | 2018 | 71 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 87 | 0.150 |
Why?
|
| Alanine | 2 | 2008 | 27 | 0.150 |
Why?
|
| Cell Nucleus | 1 | 2017 | 105 | 0.140 |
Why?
|
| Mutant Proteins | 2 | 2013 | 13 | 0.130 |
Why?
|
| Structure-Activity Relationship | 3 | 2013 | 82 | 0.130 |
Why?
|
| Cisplatin | 3 | 2018 | 69 | 0.130 |
Why?
|
| Oligonucleotides | 1 | 2015 | 27 | 0.130 |
Why?
|
| Guanine | 2 | 2017 | 14 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2014 | 14 | 0.120 |
Why?
|
| Mutagenesis | 1 | 2014 | 32 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2014 | 9 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 481 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 51 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2013 | 14 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 60 | 0.120 |
Why?
|
| Operon | 1 | 2012 | 1 | 0.110 |
Why?
|
| Apoproteins | 1 | 2011 | 3 | 0.100 |
Why?
|
| Enzyme Stability | 1 | 2011 | 8 | 0.100 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2011 | 6 | 0.100 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2011 | 5 | 0.100 |
Why?
|
| Hydrolysis | 1 | 2011 | 38 | 0.100 |
Why?
|
| Metals | 1 | 2011 | 16 | 0.100 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2008 | 4 | 0.100 |
Why?
|
| HIV-1 | 1 | 2011 | 44 | 0.100 |
Why?
|
| Genes, Dominant | 1 | 2011 | 26 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2011 | 35 | 0.100 |
Why?
|
| Inflammation | 1 | 2015 | 508 | 0.100 |
Why?
|
| Arginine | 2 | 2014 | 17 | 0.100 |
Why?
|
| Biocatalysis | 1 | 2010 | 19 | 0.090 |
Why?
|
| Recombinant Proteins | 5 | 2011 | 248 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2007 | 836 | 0.090 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2008 | 5 | 0.080 |
Why?
|
| DNA Mismatch Repair | 1 | 2008 | 4 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2007 | 67 | 0.080 |
Why?
|
| Granzymes | 1 | 2007 | 5 | 0.080 |
Why?
|
| DNA Glycosylases | 1 | 2007 | 3 | 0.080 |
Why?
|
| Salmonella typhi | 1 | 2007 | 10 | 0.080 |
Why?
|
| Basal Ganglia Diseases | 1 | 2007 | 1 | 0.080 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2007 | 11 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2007 | 40 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 142 | 0.070 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2006 | 1 | 0.070 |
Why?
|
| Proteins | 1 | 2007 | 140 | 0.070 |
Why?
|
| DNA Polymerase III | 1 | 2005 | 1 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 23 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 20 | 0.070 |
Why?
|
| Electrons | 1 | 2005 | 11 | 0.060 |
Why?
|
| Protein Folding | 1 | 2005 | 28 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 73 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 136 | 0.060 |
Why?
|
| Adenine | 2 | 2017 | 15 | 0.060 |
Why?
|
| Bacteriophage T7 | 1 | 2002 | 1 | 0.060 |
Why?
|
| Time Factors | 1 | 2008 | 2003 | 0.060 |
Why?
|
| Alleles | 2 | 2015 | 251 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2002 | 42 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2004 | 251 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 546 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 1079 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 641 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 2018 | 6 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2018 | 64 | 0.040 |
Why?
|
| Uracil | 1 | 2017 | 6 | 0.040 |
Why?
|
| Base Pair Mismatch | 1 | 2017 | 7 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2018 | 50 | 0.040 |
Why?
|
| Nanotechnology | 1 | 2017 | 15 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 159 | 0.040 |
Why?
|
| Pedigree | 2 | 2007 | 133 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 98 | 0.040 |
Why?
|
| Cell Line | 2 | 2007 | 450 | 0.030 |
Why?
|
| Antibodies | 1 | 2015 | 53 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 46 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2014 | 23 | 0.030 |
Why?
|
| Lysine | 1 | 2013 | 24 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 74 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 65 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 48 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 629 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 72 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2013 | 131 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2014 | 370 | 0.030 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2011 | 1 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2011 | 11 | 0.030 |
Why?
|
| Nucleosides | 1 | 2011 | 10 | 0.030 |
Why?
|
| Female | 3 | 2018 | 18241 | 0.030 |
Why?
|
| Cattle | 1 | 2011 | 100 | 0.030 |
Why?
|
| Virus Replication | 1 | 2011 | 47 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 212 | 0.020 |
Why?
|
| Virulence | 1 | 2010 | 19 | 0.020 |
Why?
|
| Hexuronic Acids | 1 | 2010 | 31 | 0.020 |
Why?
|
| Glucuronic Acid | 1 | 2010 | 31 | 0.020 |
Why?
|
| Alginates | 1 | 2010 | 49 | 0.020 |
Why?
|
| Reserpine | 1 | 2008 | 3 | 0.020 |
Why?
|
| Cytosine | 1 | 2008 | 9 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2008 | 15 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2008 | 30 | 0.020 |
Why?
|
| Magnesium | 1 | 2008 | 22 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2007 | 4 | 0.020 |
Why?
|
| Child | 1 | 2014 | 2221 | 0.020 |
Why?
|
| Endosomes | 1 | 2007 | 13 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2008 | 211 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 25 | 0.020 |
Why?
|
| Perforin | 1 | 2007 | 2 | 0.020 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2007 | 4 | 0.020 |
Why?
|
| Hela Cells | 1 | 2007 | 78 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 71 | 0.020 |
Why?
|
| Male | 3 | 2014 | 17876 | 0.020 |
Why?
|
| Heterozygote | 1 | 2007 | 52 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 225 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 139 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 97 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2007 | 97 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2006 | 5 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2006 | 11 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 3265 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2006 | 46 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 735 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 172 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 224 | 0.010 |
Why?
|
| Genes, Essential | 1 | 2002 | 3 | 0.010 |
Why?
|
| Genes, Viral | 1 | 2002 | 3 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 2002 | 7 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 1604 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 87 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 8468 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 3550 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 441 | 0.010 |
Why?
|